Clinical Center News
December 2023 / January 2024

Scientists searching for treatments for severe aplastic anemia

blood smear under a microscope

The National Heart, Lung, and Blood Institute seeks adults with severe aplastic anemia (SAA) for a research study determining viability and safety of early initiation of oral therapy with cyclosporine and eltrombopag in patients with SAA. All patients will receive standard treatment with cyclosporine, eltrombopag and Horse Anti-thymocyte-Globulin (h-ATG) unless there is complete count recovery with oral therapy. Compensation will be provided.

For more information, contact the Office of Patient Recruitment at 1-866-444-2214 (TTY user dial 7-1-1) of visit Refer to study 20-H-0033.

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at